| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.66 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |